MACROGENICS INC MGNX

Latest FY: 2025 Healthcare Biotechnology
Market Price $4.25
Market Cap $270.14M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-0.3% YoY
$149.50M
3-Yr CAGR: -0.5%
Net Income ↓-11.4% YoY
-$74.62M
Net Margin: -49.9%
Free Cash Flow ↓-15.1% YoY
-$82.95M
FCF Yield: -30.71%
EPS (Diluted) ↓-10.3% YoY
$-1.18
Basic: $-1.18
Return on Equity Efficiency
-134.2%
ROA: -29.1%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (MGNX)

All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
  • FY 2020: Revenue YoY (+63.4%) is identical to Gross Profit YoY (+63.4%). Verify the underlying Revenue and Gross Profit values for FY 2020 and FY 2019.
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $91.9M $-30.2M $-58.5M $-1.69 0.00% $-43.7M $-55.1M
FY 2017 $157.7M +71.7% $10.5M $-19.6M +66.5% $-0.54 +68.0% 0.00% $14.4M $-15.0M +72.8%
FY 2018 $60.1M -61.9% $-130.7M $-171.5M -773.6% $-4.19 -675.9% 0.00% $-153.2M $-178.2M -1,088.1%
FY 2019 $64.2M +6.8% $64.2M $-151.8M +11.5% $-3.16 +24.6% 0.00% $-134.3M $-138.6M +22.2%
FY 2020 $104.9M +63.4% $104.9M $-129.7M +14.5% $-2.47 +21.8% 0.00% $-111.9M $-117.8M +15.0%
FY 2021 $77.4M -26.2% $74.8M $-202.1M -55.8% $-3.37 -36.4% 0.00% $-143.8M $-150.0M -27.4%
FY 2022 $151.9M +96.2% $148.6M $-119.8M +40.7% $-1.95 +42.1% 0.00% $-87.0M $-90.6M +39.6%
FY 2023 $58.7M -61.3% $57.3M $-9.1M +92.4% $-0.15 +92.3% 0.00% $-78.2M $-80.0M +11.7%
FY 2024 $150.0M +155.3% $148.8M $-67.0M -639.3% $-1.07 -613.3% 0.00% $-68.4M $-72.1M +9.9%
FY 2025 $149.5M -0.3% $141.0M $-74.6M -11.4% $-1.18 -10.3% 0.00% $-81.0M $-83.0M -15.1%
$

Valuation

Market Price $4.25
Market Cap $270.14M
Enterprise Value $212.93M
P/E Ratio N/A
P/B Ratio 4.86
FCF Yield -30.71%
Dividend Yield N/A
Shares Outstanding 63,563,100
%

Profitability & Margins

Gross Margin 94.31%
Operating Margin -48.72%
Net Margin -49.91%
Return on Equity (ROE) -134.23%
Return on Assets (ROA) -29.05%
Asset Turnover 0.58x
Revenue 3-Yr CAGR -0.54%
🛡️

Financial Health & Liquidity

Current Ratio 5.10
Cash Ratio 1.33
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $57.22M
Total Debt N/A
Book Value / Share $0.87
💧

Cash Flow Efficiency

Operating Cash Flow -$81.04M
Capital Expenditures (CapEx) $1.91M
Free Cash Flow -$82.95M
OCF / Revenue -54.21%
FCF / Revenue -55.49%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-1.18
EPS (Basic) $-1.18
Dividends / Share N/A
Book Value / Share $0.87
EPS YoY Growth -10.28%
🏛️

Balance Sheet (FY 2025)

Total Assets $256.85M
Total Liabilities $201.25M
Stockholders' Equity $55.59M
Current Assets $219.94M
Current Liabilities $43.12M